Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endologix Inc. ELGXQ

Healthcare
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the... see more

Recent & Breaking News (OTCPK:ELGXQ)

Endologix Honors Innovators of Aortic Therapy at VEITHsymposium

Business Wire November 15, 2018

The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut

Benzinga.com  November 13, 2018

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire November 8, 2018

Endologix Reports Third Quarter 2018 Financial Results

Business Wire November 1, 2018

Endologix, Inc. to Present at Two Investor Conferences in November

Business Wire October 29, 2018

The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default

Benzinga.com  October 26, 2018

Endologix Announces Pricing of Public Offering of Common Stock

Business Wire October 25, 2018

Endologix Announces Public Offering of Common Stock

Business Wire October 24, 2018

The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering

Benzinga.com  October 24, 2018

Endologix, Inc. to Announce Third Quarter 2018 Financial Results on November 1, 2018

Business Wire October 22, 2018

FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall

Business Wire October 5, 2018

Mid-Day Market Update: Dow Up 130 Points; Kala Pharmaceuticals Shares Slide

Benzinga.com  October 3, 2018

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  October 3, 2018

The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares

Benzinga.com  October 3, 2018

8 Stocks To Watch For October 3, 2018

Benzinga.com  October 3, 2018

7 Stocks Moving In Tuesday's After-Hours Session

Benzinga.com  October 2, 2018

Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range

Business Wire October 2, 2018

Endologix Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire August 23, 2018

Endologix to Host Investor Meeting on October 2, 2018

Business Wire August 23, 2018

Endologix Appoints Jeffrey S. Brown as Chief Operations Officer

Business Wire August 15, 2018